857135C

18:1 BMP (S,S)

sn-(3-oleoyl-2-hydroxy)-glycerol-1-phospho-sn-1′-(3′-oleoyl-2′-hydroxy)-glycerol (ammonium salt), chloroform

• Synonym(e): lysobisphosphatidic acid; LBPA
• Empirische Formel (Hill-System): C₄₂H₈₂NO₁₀P
• CAS-Nummer: 1246303-12-7
• Molekulargewicht: 792.07
• UNSPSC-Code: 51191904
• NACRES: NA.25

Eigenschaften

• Assay: >99% (BMP (contains 30% positional isomers), TLC)
• Form: liquid
• Verpackung: pkg of 1 × 1 mL (857135C-10mg); pkg of 1 × 1 mL (857135C-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 857135C
• Konzentration: 10 mg/mL (857135C-10mg); 5 mg/mL (857135C-5mg)
• Lipid-Typ: phospholipids; cardiolipins
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@](COP(OC[C@@]([H])(O)COC(CCCCCCC/C=C\CCCCCCCC)=O)([O-])=O)(O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+]

Beschreibung

Anwendung

18:1 bis(monoacylglycerol)phosphate (BMP) (S,S) may be used as an standard in liquid chromatography-mass spectrometry (LC/MS) analysis for the quantification of BMP in mice tissues.

Verpackung

5 mL Clear Glass Sealed Ampule (857135C-10mg)

5 mL Clear Glass Sealed Ampule (857135C-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372
• P-Sätze: P202 - P301 + P312 - P302 + P352 - P304 + P340 + P311 - P305 + P351 + P338 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3
• Zielorgane: Liver,Kidney, Respiratory system
• Lagerklassenschlüssel: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• WGK: WGK 3
• Flammpunkt (°F): does not flash
• Flammpunkt (°C): does not flash